Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Innovax 9vHPV Vaccine vs Gardasil 9 in Healthy Females
NCT04782895Phase 3Completed
- Sponsor
- Xiamen University
- Start
- Mar 2021
- Primary completion
- May 2022
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human papillomavirus 9-valent vaccine in Cervical Cancer (CC), condylomata acuminata, sponsored by Xiamen University. Started Mar 2021; status: completed.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
Cervical Cancer (CC)condylomata acuminata
Beyond the preview
Go deeper on NCT04782895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04782895.